Ad is loading...
NSFBX vs RDBTX
NSFBX vs RDBTX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
NSFBX vs. RDBTX commentary
Feb 23, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NSFBX is a Buy and RDBTX is a Hold.
FUNDAMENTALS
Fundamentals
RDBTX has more cash in the bank: 4.89B vs. NSFBX (4.36M). RDBTX pays higher dividends than NSFBX: RDBTX (2.62) vs NSFBX (2.45). NSFBX was incepted earlier than RDBTX: NSFBX (8 years) vs RDBTX (18 years). NSFBX is a more actively managed with annual turnover of: 22.00 vs. RDBTX (7.00). RDBTX has a lower initial minimum investment than NSFBX: RDBTX (250) vs NSFBX (1000000). RDBTX annual gain was more profitable for investors over the last year : 7.98 vs. NSFBX (2.68). RDBTX return over 5 years is better than : 15.06 vs. NSFBX (-6.95).
| NSFBX | RDBTX | NSFBX / RDBTX | |
| Total Expense Ratio | N/A | N/A | - |
| Annual Report Gross Expense Ratio | N/A | N/A | - |
| Fund Existence | 8 years | 18 years | - |
| Gain YTD | 2.043 | 2.946 | 69% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 250 | 400,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 4.36M | 4.89B | 0% |
| Annual Yield % from dividends | 2.45 | 2.62 | 94% |
| Returns for 1 year | 2.68 | 7.98 | 34% |
| Returns for 3 years | 1.72 | 7.25 | 24% |
| Returns for 5 years | -6.95 | 15.06 | -46% |
| Returns for 10 years | N/A | 26.23 | - |
View a ticker or compare two or three
VS
VS
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FPHAX | 27.37 | 0.29 | +1.07% |
| Fidelity Select Pharmaceuticals Port | |||
| QBDSX | 8.03 | 0.01 | +0.12% |
| Quantified Managed Income Investor | |||
| JMNCX | 12.68 | -0.10 | -0.78% |
| JPMorgan Research Market Neutral C | |||
| SUWIX | 34.91 | -0.68 | -1.91% |
| DWS Core Equity Inst | |||
| PSMPX | 5.47 | -2.66 | -32.69% |
| Penn Capital Mid Cap Core Inst | |||